ARTICLE | Distillery Therapeutics
Cancer
October 4, 2018 4:16 PM UTC
Cell culture, mouse and patient-derived organoid studies identified a benzothiophene-benzothiazole-based BIRC2 inhibitor that could help treat breast cancer and leukemias. Screening of 50,000 small mo...
BCIQ Target Profiles